News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Study Participants Want to Know
Jef Akst | Apr 29, 2015
Most people who participate in research that involves genetic testing prefer to be told if they have mutations that increase their risk of treatable disease, according to a large survey.
Jenny Rood | Apr 21, 2015
Color Genomics announces a new, lower-cost BRCA mutation test, while Inserm and Quest Diagnostics reveal plans to pool patient data to investigate rare mutations.
FDA OKs 23andMe Test
Kerry Grens | Feb 20, 2015
The US Food and Drug Administration will allow the personal genomics company to resume a disease-risk analysis.
23andMe Expands to U.K.
Kerry Grens | Dec 2, 2014
British consumers can buy the genetic testing-associated health prediction service forbidden by the US government.
Snakebites Get DNA Fingerprint Treatment
Bob Grant | Nov 4, 2014
Researchers have developed a technique for determining the species of snake responsible for a bite by sequencing genetic material from the fang marks.
Australian Court Upholds Patents on Human Genes
Molly Sharlach | Sep 8, 2014
The Federal Court of Australia rejected an appeal of a ruling that allows companies to patent isolated human genes.
Patent Plea Ping Pong
Kerry Grens | Aug 21, 2014
A genetic testing firm accused of infringing upon Myriad Genetics’s gene patents fights back in an attempt to wipe other patents out.
DNA Ancestry for All
Tracy Vence | Jul 10, 2014
Big ad campaigns and celebrity involvement have helped increase public interest in genetic genealogy, but helping consumers understand their DNA ancestry testing results remains difficult.
Speaking of Science
Staff | Jan 1, 2014
January 2014's selection of notable quotes
The Right to Know—or Not
Tracy Vence | Dec 12, 2013
Consumers, patients, and study participants should be made aware of potential incidental findings, according to a federally-appointed bioethics panel.